Stocks to Watch in 2025, as we look ahead to 2025, several stocks are generating buzz among investors and analysts alike.
 

1. Phio Pharmaceuticals (NASDAQ: PHIO)

Great Clinical Results
Phio Pharmaceuticals has reported encouraging findings from its ongoing clinical study of PH-762, with patients in the second cohort achieving a pathologic complete response. Utilizing its innovative INTASYL Registered siRNA gene silencing technology, Phio aims to enhance immune cell effectiveness in targeting cancer, positioning itself as a leader in next-generation oncology treatments.
 

2. LightPath Technologies (NASDAQ: LPTH)

Analyst Upgrades and Defense Innovations
LightPath Technologies is gaining attention as Lake Street Capital Markets raised its price target to $4 from $3 while maintaining a "Buy" rating. The company’s FPV drone infrared lens assemblies, developed for a prominent European defense customer, are expected to significantly boost revenue in 2025. LightPath also appeared on Bloomberg Television, showcasing its contributions to advanced military defense technologies.
 

3. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL)

Strategic Merger Progress
Kaival Brands, a distributor of Bidi Registered Stick products, has filed a Form F-4 registration statement with the SEC to advance its business combination with Delta Corp Holdings Limited. This merger will establish a new publicly traded company listed on Nasdaq, with the transaction expected to close by February 2025.
 

4. Sage Therapeutics, Inc. (NASDAQ: SAGE)

Expanding Market Reach
Sage Therapeutics is focusing on accelerating market growth for its ZURZUVAE Registered (zuranolone), the first and only once-daily 14-day oral treatment for postpartum depression (PPD). Increased investment in ZURZUVAE aims to support topline revenue growth in 2025, with projections for reduced expenses and an extended cash runway to mid-2027.
 

5. Agape ATP Corp (NASDAQ: ATPC)

Innovative Health Solutions
Agape ATP Corp offers a range of health and wellness solutions through its ATP Zeta Health Program, ENERGETIQUE skincare line, and BEAUNIQUE nutrigenomic products. With a focus on cellular health and personalized nutrition, the company is well-positioned to meet the growing demand in the wellness industry throughout 2025.
 

6. CS Diagnostics (OTCQB: CSDX)

Advancements in Healthcare Solutions
CS Diagnostics announced significant progress toward the U.S. launch of a new innovative healthcare solution, including its CS Protect-Hydrogel. This hydrogel-based tissue spacer is designed to enhance protection during cancer treatment by increasing the distance between cancer cells and healthy tissue. The new product focuses on both B2B and B2C markets.
 

Conclusion

These companies exemplify the dynamic opportunities available to investors in 2025. With advancements in healthcare solutions, cutting-edge technologies, and innovative wellness products, stocks like Phio Pharmaceuticals, LightPath Technologies, and Sage Therapeutics are driving growth and setting trends worth monitoring this year. Investors seeking exposure to high-potential sectors should keep these names on their radar.
 

When considering shares, indices, forex (foreign exchange) and commodities for trading and price predictions, remember that trading CFDs involves a significant degree of risk and could result in capital loss. 

Past performance is not indicative of any future results. This information is provided for informative purposes only and should not be construed to be investment advice.